Records 1 - 9
| Predictive clinical-genetic model of long-term non-response to tumor necrosis factor-alpha inhibitor therapy in spondyloarthritis.
International journal of rheumatic diseases 2019 May .
Polo Y La Borda Jessica, Campos José, Sanz Jesús, Andréu José Luis, Mulero Juan, Sánchez Alejand
| The Influence of FTO Polymorphism rs9939609 on Obesity, Some Clinical Features, and Disturbance of Carbohydrate Metabolism in Patients with Psoriasis.
BioMed research international 2019 2019 7304345.
Tupikowska-Marzec Malgorzata, Kolackov Katarzyna, Zdrojowy-Welna Aleksandra, Sloka Natalia K, Szepietowski Jacek C, Maj
| MiR-146a G/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis.
BMC medical genetics 2018 Mar 19 (1): 48.
Maharaj Ajesh B, Naidoo Pragalathan, Ghazi Terisha, Abdul Naeem S, Dhani Shanel, Docrat Taskeen F, Ramkaran Prithiksha, Tak Paul-Peter, de Vries Niek, Chuturgoon Anil
| Association of C-Reactive Protein (rs1205) Gene Polymorphism with Susceptibility to Psoriasis in South Indian Tamils.
Journal of clinical and diagnostic research : JCDR 2016 Oct 10 (10): GC01-GC04.
Sudhesan Anjana, Rajappa Medha, Chandrashekar Laxmisha, Ananthanarayanan Palghat Hariharan, Thappa Devinder Mohan, Satheesh Santhosh, Chandrasekaran Adithan, Devaraju Panne
| Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris.
Journal of clinical laboratory analysis 2016 Apr .
Zhou Zhen-Xing, Chen Jian-Kui, Hong Yan-Ying, Zhou Ru, Zhou Dong-Mei, Sun Li-Yun, Qin Wen-Li, Wang Tian-Che
| High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.
International journal of dermatology 2016 Jan .
Itani Salam, Arabi Asma, Harb Dana, Hamzeh Diana, Kibbi Abdul-Gha
| Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese.
Molecular biology reports 2012 Apr 39 (4): 4111-7.
Chang Ya-Ching, Wu Wei-Ming, Hsu Lung-
| Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis.
Drug metabolism and disposition: the biological fate of chemicals 2009 Oct 37 (10): 2061-8.
Bohanec Grabar Petra, Grabnar Iztok, Rozman Blaz, Logar Dusan, Tomsic Matija, Suput Dasa, Trdan Tina, Peterlin Masic Lucija, Mrhar Ales, Dolzan Vi
| Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases.
BMC medical genetics 2006 7 (): 20.
Smyth Deborah J, Howson Joanna M M, Payne Felicity, Maier Lisa M, Bailey Rebecca, Holland Kieran, Lowe Christopher E, Cooper Jason D, Hulme John S, Vella Adrian, Dahlman Ingrid, Lam Alex C, Nutland Sarah, Walker Neil M, Twells Rebecca C J, Todd John